The Pharmacokinetics of Fondaparinux Sodium in Healthy Volunteers

被引:0
|
作者
François Donat
Jean Pierre Duret
Alix Santoni
Roger Cariou
José Necciari
Harry Magnani
Rik de Greef
机构
[1] Sanofi-Synthelabo Groupe,
[2] Organon,undefined
来源
Clinical Pharmacokinetics | 2002年 / 41卷
关键词
Venous Thromboembolism; Fondaparinux; Elderly Volunteer; Young Volunteer; Subcutaneous Dose;
D O I
暂无
中图分类号
学科分类号
摘要
Objective: Fondaparinux sodium is the first in a new class of synthetic factor Xa inhibitors that binds reversibly with high affinity to antithrombin III. It has been investigated for the prevention and treatment of arterial and venous thrombotic disorders and approved for use at a dose of 2.5mg once daily in the prevention of venous thromboembolism in major orthopaedic surgery. The pharmacokinetics of fondaparinux sodium were determined in eight studies in young and elderly healthy volunteers.
引用
收藏
页码:1 / 9
页数:8
相关论文
共 50 条
  • [1] The pharmacokinetics of fondaparinux sodium in healthy volunteers
    Donat, F
    Duret, JP
    Santoni, A
    Cariou, R
    Necciari, J
    Magnani, H
    de Greef, R
    [J]. CLINICAL PHARMACOKINETICS, 2002, 41 (Suppl 2) : 1 - 9
  • [2] Absence of Interaction of Fondaparinux Sodium with Digoxin in Healthy Volunteers
    Timothy Mant
    Philippe Fournié
    Céline Ollier
    François Donat
    José Necciari
    [J]. Clinical Pharmacokinetics, 2002, 41 : 39 - 45
  • [3] Absence of interaction of fondaparinux sodium with digoxin in healthy volunteers
    Mant, T
    Fournié, P
    Ollier, C
    Donat, F
    Necciari, J
    [J]. CLINICAL PHARMACOKINETICS, 2002, 41 (Suppl 2) : 39 - 45
  • [4] Absence of Interaction of Fondaparinux Sodium with Aspirin and Piroxicam in Healthy Male Volunteers
    Céline Ollier
    Richard A. Faaij
    Alix Santoni
    Thierry Duvauchelle
    Paul M. M. van Haard
    Rik C. Schoemaker
    Adam F. Cohen
    Rik de Greef
    Jacobus Burggraaf
    [J]. Clinical Pharmacokinetics, 2002, 41 : 31 - 37
  • [5] Absence of interaction of fondaparinux sodium with aspirin and piroxicam in healthy male volunteers
    Ollier, C
    Faaij, RA
    Santoni, A
    Duvauchelle, T
    van Haard, PMM
    Schoemaker, RC
    Cohen, AF
    de Greef, R
    Burggraaf, J
    [J]. CLINICAL PHARMACOKINETICS, 2002, 41 (Suppl 2) : 31 - 37
  • [6] Pharmacokinetics of Inhaled Treprostinil Sodium in Healthy Volunteers
    Nelsen, A. C.
    Laliberte, K. J.
    Zaccardelli, D. S.
    Gotzkowsky, S. K.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [7] PHARMACOKINETICS OF FONDAPARINUX IN HEALTHY CATS
    Fiakpui, N. N.
    Hogan, D. F.
    Whittem, T.
    Green, H. W., III
    Shipley, E. A.
    Sederquist, K. A.
    [J]. JOURNAL OF VETERINARY INTERNAL MEDICINE, 2010, 24 (03) : 694 - 694
  • [8] Sodium thiosulfate pharmacokinetics in hemodialysis patients and in healthy volunteers
    Stauffer, E.
    Farese, S.
    Kalicki, R.
    Hildebrandt, T.
    Frey, F. J.
    Frey, B.
    Uehlinger, D. E.
    Pasch, A.
    [J]. SWISS MEDICAL WEEKLY, 2010, 140 : 6S - 6S
  • [9] Sodium Thiosulfate Pharmacokinetics in Hemodialysis Patients and Healthy Volunteers
    Farese, Stefan
    Stauffer, Emilie
    Kalicki, Robert
    Hildebrandt, Tatjana
    Frey, Brigitte M.
    Frey, Felix J.
    Uehlinger, Dominik E.
    Pasch, Andreas
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (06): : 1447 - 1455
  • [10] Tolerability and Pharmacokinetics of Repeated Doses of Dersalazine Sodium in Healthy Volunteers
    Fernandez-Deamo, Natalia
    Solans, Anna
    Vives, Roser
    Pontes, Caridad
    Merlos, Manuel
    [J]. GASTROENTEROLOGY, 2010, 138 (05) : S522 - S522